Korea Joongang Daily
Korea JoongAng Daily

Celltrion to cancel 1.7 trillion won in treasury shares to boost shareholder value

Celltrion, a major Korean biopharmaceutical company, said Wednesday it will cancel 1.7 trillion won ($1.1 billion) worth of treasury shares this month as part of efforts to enhance shareholder value.

2026-04-01

Number of M&As under review in Korea down in 2025, but total value up 30%: Watchdog

Korea's antitrust regulator said that the number of reviewed mergers and acquisitions (M&As) declined from a year earlier in 2025, but the total value of the deals surged nearly 30 percent, indicating an increase in large-scale transactions.

2026-02-04

Major M&A activity drops by 40% in 2024, industry data shows

Merger and acquisition (M&A) investments by major Korean businesses have plummeted by around 40 percent this year, industry data showed Wednesday.

2024-12-18